Natixis

SEC CIK: 0001274981
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

ALDX holding history

Aldeyra Therapeutics, Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALDX overview All 13F holders of ALDX Full Q2 2026 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2022

Holdings of ALDX by Natixis, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−674,549−100.0%	Sold out	Holders
Q1 2023	674,549	$6.70M	0.1%	+630,291+1,424.1%	Added	Holders
Q4 2022	44,258	$308.0K	<0.1%	+44,258	New	Holders